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Psoriasis (Ps) is an autoimmune chronic skin disease with a high prevalence in the general population. Connective tissue diseases
(CTD) are also autoimmune disorders of unknown cause with highly variable clinical expression. The combination of CTD and
psoriasis is uncommon and has rarely been described. We report two cases of CTD associated with psoriasis: a case of systemic lupus
erythematosus (SLE) and a case of Sjogren syndrome (SS)s.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Psoriasis (Ps) is an autoimmune chronic inﬂammatory
skin disease. Its prevalence in the general population is esti-
mated at 2.8%. Connective tissue diseases (CTD) are also
autoimmune disorders with highly variable clinical expres-
sion of unknown cause in occur genetic factors, endocrine,
immunological and environmental factors. The combina-
tion of CTD and psoriasis is uncommon and has rarely
been described. We report two cases of CTD associated
with psoriasis.
2. Case report 1
A 29-year-old woman, without notable medical history,
hospitalized because of fever, asthenia, rash of the face,http://dx.doi.org/10.1016/j.jdds.2015.04.001
2352-2410/ 2015 The Authors. Production and hosting by Elsevier B.V. on
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before admission. Physical examination objectiﬁed a malar
rash, temporal alopecia, a scalp psoriasis and arthritis in
his right knee. Blood count showed a normochromic nor-
mocytic anemia at 10.5 g/dl, lymphopenia at 1300/mm3
and thrombocytopenia at 60000/mm3. Immunological tests
showed positive ANA at 1/320, anti DNAn positive at
180 IU/ml and Ac anti Ro positive. Skin biopsy revealed
a granular immunoﬂuorescence of the dermo-epidermal:
IgG+, IgM+, IgA+ in the pathological zone and C4++
the in healthy zone. The diagnosis of SLE is held before
5 ARA criteria and diagnosis of psoriasis is chosen after
considering dermatological specialist. The patient was trea-
ted by corticosteroids at 1 mg/kg/day for the thrombocy-
topenia and progressively degreased. She was treated also
by hydroxychloroquine (Plaquenil) at 6.5 mg/kg/day.
The association of me´thotrexate was discussed, but not
used. The evolution was favorable with a decline of 2 years.3. Case report 2
A 44-year-old female, was referred to the department of
internal diseases for Raynaud’s phenomena and dryness ofbehalf of King Saud University.
commons.org/licenses/by-nc-nd/4.0/).
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dryness over the oral mucosa. There was no hepatomegaly,
no splenomegaly, no parotid hypertrophia, nor lymph
nodes. Cardiopulmonary and neurological examinations
were normal. On ophthalmological exam, ocular dryness
was objectively assessed. Laboratory data revealed a
polyclonal hyperglobulinemia (21 g/l) on the serum elec-
trophoresis examination. Protidemia and albuminemia
were within reference limits. The white blood cell count
was 7200/mm3 without lymphopenia and the hemoglobin
level was 11.4 g/dl. Inﬂammatory indices, erythrocyte sedi-
mentation rate and C-reactive protein were increased. Her
liver function was normal. Positive anti-Ro autoantibodies
were found. A chest X-ray was without abnormalities.
Anatomo-pathological examination of salivary glands
biopsy showed lymphocytic sialadenitis grade IV. Sjogren
syndrome (SS) was diagnosed according to the new classi-
ﬁcation criteria for SS (SICCA Group 2012). The diagnosis
of primary SS was retained after eliminating other auto-im-
mune and connective tissue diseases. Symptomatic treat-
ment was indicated with a favorable evolution. Two
years later, she consulted for chronic small erythemato
squamous plaques localized in the elbows and the knees
(Fig. 1). The diagnosis of psoriasis was retained after con-
sidering a dermatological specialist. The patient was trea-
ted by local corticosteroids with good response.
4. Discussion
The pathogenesis of psoriasis is still unclear, but it is
thought to be related to a polygenic predisposition and aFig. 1. Erythemato squamonumber of environmental factors, such as stress, infection,
and drugs (Nestle et al., 2009). Psoriasis shares both
immunologic and genetic risk factors with other
autoimmune diseases such as connective tissue diseases
(Cuesta-Montero and Belincho´n, 2011). The most common
mediator in both psoriasis and connective tissue diseases is
TH17 cell a novel CD4 T eﬀector (Pernis, 2009; Tesmer
et al., 2008; Afzali et al., 2007).
The coexistence of Ps and SLE is uncommon. The ﬁrst
case report was published in 1927 by O’Leary (1936) and
since then most cases of concomitant Ps and SLE in the
literature are anecdotal reports and small case series (Ben
Dhaou et al., 2013; Lynch and Roenigk, 1978;
Winchester et al., 2012; Hays et al., 1984).
In typical forms, the diﬀerential diagnosis between SLE
and Ps is easy. But sometimes psoriasiform lesions due to
subacute lupus can be confused with psoriasis lesions
(Cuesta-Montero and Belincho´n, 2011; Ferahbas et al.,
2004). In our observation the diagnosis of psoriasis was
evident and based on dermatological specialist exam.
In 1993, Kulick et al. (1983) studied a series of 4 patients
with coexistent LE and psoriasis and 24 with psoriasis
alone. The 4 patients with the combination all presented
the anti-Ro antibody while the 24 controls did not. These
authors also described the potential severity of photosensi-
tive reactions in patients with this combination, which are
probably linked to the anti-Ro antibody. Anti-Ro antibody
may be a marker of the association between psoriasis and
LE. But, Hays et al. (Goucha et al., 2005; Hays et al.,
1984) later reported on 4 patients with LE and psoriasis
in whom the anti-Ro antibody was not found. Thisus plaques in the knees.
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the case reported by Goucha et al. (2005). In the case of our
patient anti Ro antibody was found but this association
could be not speciﬁc.
Choice of treatment in concurrent SLE and psoriasis is
diﬃcult. Antimalarial agents are beneﬁcial to manage
SLE but their eﬀect on the course of psoriasis is debated
(Sorbara et al., 2005). Systemic corticosteroids are pre-
scribed to manage some forms of SLE. In theory, the sys-
temic use of corticosteroids would be contraindicated in
patients with psoriasis because of the possibility of psoria-
tic erythroderma (Van Del Kerkhof et al., 2008). In our
case corticoids were used with no eﬀects on psoriasis.
Methotrexate used in our patient without no side eﬀects
has been used successfully to treat patients with coexistent
SLE and psoriasis in other series (Callen, 2004).
The association between Sjogren syndrome and Ps was
exceptionally described. Only some cases have been
reported. Toshiyuki et al. (Yamamoto et al., 1996) reported
5 cases of coexistent psoriasis and SS, two patients with
psoriasis vulgaris and one patient with generalized pustular
psoriasis. In the diagnosis of Ps can be concomitant to
Sjogren syndrome or after this one. In our case Ps was
diagnosed two years after SS diagnosis. The treatment by
antimalarial agents can be beneﬁcial but its eﬀect on the
course of psoriasis is debated. However, in reported cases,
the course of psoriasis was not altered when hydroxy-
chloroquine was prescribed (Callen, 2004).
5. Conclusion
Psoriasis is a relatively common disease in the general
population but its simultaneous occurrence with connective
tissue diseases is rare. The implications of such associations
are important to be known given the pathogenic and thera-
peutic problems they raise. Individual assessment of each
patient is essential and requires collaboration between
internist and dermatologist.
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